International Myeloma Foundation
MYELOMA MINUTE | Up To The Minute News | 09.03.2020
COVID-19 UPDATE: How to Stay Safe in a Time of Uncertainty
As the COVID-19 pandemic wears on, it’s becoming more difficult to simply stay at home to stay safe. What types of guidelines should myeloma patients follow when they need to venture away from home? IMF Chairman Brian G.M. Durie shares travel guidance and sheds light on the latest COVID-19 research.
FDA Grants Priority Review for a Drug Combination Using Melflufen for Triple-Class Refractory Multiple Myeloma
On August 29, 2020, the FDA granted priority review “for Oncopeptides' New Drug Application seeking approval of melflufen (INN melphalan flufenamide), in combination with dexamethasone for the treatment of adult patients with multiple myeloma whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent and one anti-CD-38 monoclonal antibody, (i.e., triple-class refractory multiple myeloma patients).”
Hot Off the Press: Summer 2020 Edition of Myeloma Today
The Summer 2020 edition of Myeloma Today is now available as a free download or printed copy. Read about the highlights of virtual 2020 annual meetings of ASCO and EHA, and more. Medical content is translated and available in French, Italian, German, and Spanish.
Listen to "A Day in the Life" Podcast with Guest Tim Gavallas
In this podcast, listen to multiple myeloma patient Tim Gavallas share what gives him hope, or in Tim’s words, “I just value every day, and I treat it as a gift. I look to make memories, especially with my sons. They grow up so fast. There’d be times when I might be tired, and I had a long day at work, and I come home. They’ll ask me to play catch or something like that. Without having myeloma, maybe some of those times, you might say no because you are tired. I always make sure I get up, and I go out and just make those memories, the lasting memories. In the end, that’s all you are going to take with you.”
ONS 2020 Web Banner Final
Attention Oncology Nurses!
Register NOW for a FREE CNE-accredited symposium on best practices and innovations in myeloma care. Four highly experienced nurses will share real-life patient case scenarios. This IMF-hosted virtual symposium takes place on September 8, 2020, at 2 p.m. PT / 5 p.m ET.
Participate in the Miracles for Myeloma 5K from Anywhere in the World!
All you have to do is register between NOW and September 26th at 8 a.m. PT / 11 a.m. ET to take part in this year’s Global Virtual Miracles for Myeloma 5K, along with thousands of others. Run, walk, bike, or use a treadmill to complete the 5K!  Choose your virtual run and finish it at your pace. You can even run one mile a day over the course of three days, or complete the full run at one time. Prizes will be awarded for those who raise the most funds, or put together a large virtual team. Join the fun today!
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series
This Week’s Question:

What are bispecific antibodies?
Watch Now
Clinical Trials
OCEAN Trial (Now Accruing)

IKEMA Trial (Fully Accrued)

IMROZ Trial (Fully Accrued)

BOSTON Trial (Fully Accrued)
Search the Myeloma Matrix 2.0

Smart Patients: Join the Conversation
Upcoming Events
Learn More
Blood Cancer Awareness Month

Watch a Replay
IMF Patient & Family Webinar

Smile More Auction
Laughs 4 Life

Click here to see all events

We Thank Our Sponsors:

Amgen; Bristol-Myers Squibb; Genentech; GSK; Oncopeptides, Inc.; Sanofi-Genzyme; and Takeda Oncology
We also thank individuals like you for your continued support!
Subscribe Button@2x.jpg
Join the conversation at The International Myeloma Foundation
Facebook Facebook: /Myeloma  |  Twitter Twitter @IMFMyeloma  |  Instagram Instagram @IMFmyeloma
This email was sent by:
The International Myeloma Foundation
12650 Riverside Drive, Suite 206
North Hollywood, CA 91607-3421
Connect with the IMF InfoLine
We respect your privacy and your preferences for communications of this nature.
Home  •  Unsubscribe  •  Privacy Policy
View as web page